Fundraising FoxParadigm Capital — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.
BiotechDeep TechHealthtechBoston, US
Steve Petrou(Co-Founder, President of Research & Development)inKiran Reddy(Executive Officer, Director)inMarcio Souza(President & Chief Executive Officer)in
BoardNicholas G. Galakatos(Director)in
Co-investorsAvoro Capital AdvisorsCapria VenturesOCV PartnersAlameda ResearchAPOLLO PROJECTSBlackstone+6 more
Praxis offers an alternative to traditional college for eligible U.S. citizens, providing a program focused on self-direction, practical job skills, and a supported job search with a job-offer guarantee.
EdTechFuture of Work
Co-investorsService Provider CapitalAlameda ResearchAPOLLO PROJECTSFirework VenturesNorwest Venture PartnersPenny Jar Capital Venture+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.